• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

低收入和中等收入国家在 COVID-19 随机临床试验中的地域代表性。

Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19.

机构信息

Critical Care Division, The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

出版信息

JAMA Netw Open. 2022 Feb 1;5(2):e220444. doi: 10.1001/jamanetworkopen.2022.0444.

DOI:10.1001/jamanetworkopen.2022.0444
PMID:35212752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8881769/
Abstract

This systematic review examines geographical representation of low- and middle-income countries in randomized clinical trials for COVID-19 compared with high-income countries.

摘要

本系统评价考察了 COVID-19 随机临床试验中低收入和中等收入国家与高收入国家的地域代表性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059a/8881769/155e867cc364/jamanetwopen-e220444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059a/8881769/155e867cc364/jamanetwopen-e220444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059a/8881769/155e867cc364/jamanetwopen-e220444-g001.jpg

相似文献

1
Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19.低收入和中等收入国家在 COVID-19 随机临床试验中的地域代表性。
JAMA Netw Open. 2022 Feb 1;5(2):e220444. doi: 10.1001/jamanetworkopen.2022.0444.
2
Universal basic income and covid-19 pandemic.普遍基本收入与新冠疫情
BMJ. 2021 Jan 26;372:n193. doi: 10.1136/bmj.n193.
3
The Differential Outcomes of Coronavirus Disease 2019 in Low- and Middle-Income Countries vs High-Income Countries.2019年冠状病毒病在低收入和中等收入国家与高收入国家的不同结果
JAMA Psychiatry. 2020 Dec 1;77(12):1207-1208. doi: 10.1001/jamapsychiatry.2020.2174.
4
COVID-19 Global health crisis.COVID-19 全球健康危机。
Saudi Med J. 2021 Jan;42(1):3-4. doi: 10.15537/smj.2021.1.25663.
5
Maintaining Stroke Care During the COVID-19 Pandemic in Lower- and Middle-Income Countries: World Stroke Organization Position Statement Endorsed by American Stroke Association and American Heart Association.在中低收入国家 COVID-19 大流行期间维持卒中护理：世界卒中组织立场声明得到美国卒中协会和美国心脏协会的认可。
Stroke. 2022 Mar;53(3):1043-1050. doi: 10.1161/STR.0000000000000394. Epub 2022 Feb 28.
6
Ethical health leadership: Lessons from low- and middle-income countries during COVID-19.道德健康领导力：新冠疫情期间来自低收入和中等收入国家的经验教训。
Healthc Manage Forum. 2021 Jan;34(1):62-67. doi: 10.1177/0840470420961913. Epub 2020 Oct 5.
7
COVID-19 and global health: Influences and implications for education and training support in low- and middle-income countries.新冠疫情与全球健康：对低收入和中等收入国家教育与培训支持的影响及启示
Anaesth Intensive Care. 2020 Jul;48(4):262-265. doi: 10.1177/0310057X20949549. Epub 2020 Aug 12.
8
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector.低收入和中等收入国家的新型冠状病毒2检测：私立卫生部门的可及性与可负担性
Microbes Infect. 2020 Nov-Dec;22(10):511-514. doi: 10.1016/j.micinf.2020.10.005. Epub 2020 Oct 14.
9
Just the facts: updates in COVID-19 therapeutics.只讲事实：新冠治疗的最新进展。
CJEM. 2021 May;23(3):283-285. doi: 10.1007/s43678-020-00078-4. Epub 2021 Feb 8.
10
Rethinking the Central Role of Equity in the Global Governance of Pandemic Response.重新思考公平在大流行病应对的全球治理中的核心作用。
J Bioeth Inq. 2020 Dec;17(4):549-553. doi: 10.1007/s11673-020-10001-2. Epub 2020 Aug 25.

引用本文的文献

1
Conducting CNS trials during a public health emergency - Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper.在突发公共卫生事件期间开展中枢神经系统试验——从新冠疫情中吸取的经验教训：ISCTM/ECNP联合工作组共识文件
Neurosci Appl. 2023;2:101129. doi: 10.1016/j.nsa.2023.101129. Epub 2023 Jun 17.
2
The Current Landscape of Clinical Trials.临床试验的现状
J Clin Med. 2025 Apr 7;14(7):2519. doi: 10.3390/jcm14072519.
3
Infrastructure, capabilities, and capacities required for clinical trials design and delivery: A rapid scoping review of recommendations and regulations.

本文引用的文献

1
The Need for a Practical Approach to Evaluate the Effectiveness of COVID-19 Vaccines for Low- and Middle-Income Countries.需要采取切实可行的方法来评估 COVID-19 疫苗在中低收入国家的有效性。
Am J Trop Med Hyg. 2021 Jul 16;105(3):561-563. doi: 10.4269/ajtmh.21-0482.
2
Priorities for COVID-19 research response and preparedness in low-resource settings.资源匮乏地区针对新冠疫情研究应对与准备的优先事项。
Lancet. 2021 May 22;397(10288):1866-1868. doi: 10.1016/S0140-6736(21)00980-6. Epub 2021 May 6.
3
Health inequality among different economies during early phase of COVID-19 pandemic.
临床试验设计与实施所需的基础设施、能力和容量：对建议与法规的快速范围审查
Wellcome Open Res. 2025 Mar 6;9:729. doi: 10.12688/wellcomeopenres.23135.2. eCollection 2024.
4
Equitable Global Representation in Cardiovascular Guidelines and Clinical Trials: Lacunae Remain.心血管疾病指南和临床试验中的全球公平代表性：仍存在空白。
JACC Adv. 2024 Dec 26;3(12):101381. doi: 10.1016/j.jacadv.2024.101381. eCollection 2024 Dec.
5
Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia.酪氨酸激酶抑制剂治疗慢性髓性白血病的全球试验情况及可及性
Cancers (Basel). 2024 Aug 14;16(16):2838. doi: 10.3390/cancers16162838.
6
Understanding Heterogeneity in Acute Care Trials: Resource Availability Impacts Outcomes.理解急性护理试验中的异质性：资源可用性对结果的影响。
Am J Respir Crit Care Med. 2024 Mar 1;209(5):469-471. doi: 10.1164/rccm.202401-0232ED.
7
Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.高收入和中低收入国家 COVID-19 临床研究中的差异。
Int J Infect Dis. 2023 Jul;132:9-16. doi: 10.1016/j.ijid.2023.04.393. Epub 2023 Apr 15.
8
The need for COVID-19 clinical trials in LMICs.低收入和中等收入国家对新冠病毒临床试验的需求。
Front Public Health. 2023 Jan 9;10:1038840. doi: 10.3389/fpubh.2022.1038840. eCollection 2022.
9
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.全身性皮质类固醇治疗 COVID-19：与公平相关的分析和证据更新。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2.
10
Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries.评估 2021 年 COVID-19 疫苗市场格局与中低收入国家面临的挑战。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2124781. doi: 10.1080/21645515.2022.2124781. Epub 2022 Oct 21.
新冠疫情早期不同经济体之间的健康不平等。
J Egypt Public Health Assoc. 2021 Feb 17;96(1):3. doi: 10.1186/s42506-021-00067-0.
4
Intensive care for COVID-19 in low- and middle-income countries: research opportunities and challenges.低收入和中等收入国家的新冠重症监护：研究机遇与挑战
Intensive Care Med. 2021 Feb;47(2):226-229. doi: 10.1007/s00134-020-06285-y. Epub 2020 Nov 13.
5
Managing COVID-19 in Low- and Middle-Income Countries.低收入和中等收入国家的新冠疫情管理
JAMA. 2020 Apr 28;323(16):1549-1550. doi: 10.1001/jama.2020.4169.